Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

Despair fuels hope ...

IMU Biosciences partners with Waters to advance IMU’s AI-driven immunology platform to transform diagnosis and monitoring: London, UK Friday, June 26, 2026, 12:00 Hrs [IST] IMU ...

MILFORD, Mass., June 24, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, ...

IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a ...

IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences’ technologies, ...

Coronary artery disease remains the leading cause of death globally and is a major burden to every health system in the world. There have been significant improvements in risk modification, treatments ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, making it fundamental to medical research. As assays evolve to capture more ...

The Center for Molecular Medicine Flow cytometry Core is a research core that provides KI researchers with introduction, education and services for cell analysis and cell sorting by flow cytometry.

Flow cytometry is a key diagnostic technique in hematology that provides protein information at a single-cell level. Traditionally interpreted manually in a sequence of two-dimensional plots, ...

Flow Cytometry facilities at UCL ensure researchers have timely access to equipment, resources and expertise necessary to undertake world-leading research. The Flow Cytometry Science Technology ...